Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.

SOLITARY FIBROUS TUMOR OF THE PLEURA: OUR EXPERIENCE.

July 2015

none8Abstract n. 346 dell'Abstract book, disponibile anche online (http://content.karger.com/Produkt...

A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons.

Martin-Broto, Javier
Mondaza-Hernandez, Jose L
Moura, David S
Hindi, Nadia

June 2021

Solitary fibrous tumor (SFT) is a rare mesenchymal, ubiquitous tumor, with an incidence of 1 new cas...

A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group. Ann Oncol 6:77–79

M. Di Bartolomeo
E. Bajetta
A. M. Bochicchio
C. Carnaghi
L. Somma
V. Mazzaferro
M. Visini
V. Gebbia
S. Tumolo
P. Ballatore

January 1995

Background: Previous experiences in the treatment of neuro-endocrine tumours have demonstrated some ...

Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour

February 2018

none22noBackground Preclinical models that mimic pathological and molecular features of solitary fib...

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience.

Levard, Alice
Derbel, Olfa
Méeus, Pierre
Ranchère, Dominique
Ray-Coquard, Isabelle
Blay, Jean-Yves
Cassier, Philippe

January 2013

International audienceBACKGROUND: Solitary Fibrous Tumor is a rare type of soft tissue tumor of inte...

Dacarbazine in solitary fibrous tumor : a case series analysis and preclinical evidence vis-à-vis temozolomide and antiangiogenics

S. Stacchiotti
M. Tortoreto
F. Bozzi
E. Tamborini
C. Morosi
A. Messina
M. Libertini
E. Palassini
D. Cominetti
T. Negri
A. Gronchi
S. Pilotti
N. Zaffaroni
P.G. Casali

January 2013

Purpose: To explore the value of triazines in solitary fibrous tumor (SFT). Experimental Design: We ...

Multi-institutional European single-arm phase II trial of pazopanib in advanced malignant/dedifferentiated solitary fibrous tumors (SFT): A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) sarcoma groups study.

June 2017

none19openJavier Martin Broto; Silvia Stacchiotti; Antonio Lopez-Pousa; Andres Redondo; Daniel Berna...

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

Martin-Broto, Javier
Stacchiotti, Silvia
Lopez-Pousa, Antonio
Redondo, Andres
Bernabeu, Daniel
de Alava, Enrique
Casali, Paolo G
Italiano, Antoine
Gutierrez, Antonio
Moura, David S
Peña-Chilet, Maria
Diaz-Martin, Juan
Biscuola, Michele
Taron, Miguel
Collini, Paola
Ranchere-Vince, Dominique
Garcia del Muro, Xavier
Grignani, Giovanni
Dumont, Sarah
Martinez-Trufero, Javier
Palmerini, Emanuela
Hindi, Nadia
Sebio, Ana
Dopazo, Joaquin
Dei Tos, Angelo Paolo
LeCesne, Axel
Blay, Jean-Yves
Cruz, Josefina

January 2019

Background: A solitary fibrous tumour is a rare soft-tissue tumour with three clinicopathological va...

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: a propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

D'Ambrosio, L.
Touati, N.
Blay, J.Y.
Grignani, G.
Flippot, R.
Czarnecka, A.M.
Piperno-Neumann, S.
Martin-Broto, J.
Sanfilippo, R.
Katz, D.
Duffaud, F.
Vincenzi, B.
Stark, D.P.
Mazzeo, F.
Tuchscherer, A.
Chevreau, C.
Sherriff, J.
Estival, A.
Litiere, S.
Sents, W.
Ray-Coquard, I.
Tolomeo, F.
Cesne, A. le
Rutkowski, P.
Stacchiotti, S.
Kasper, B.
Gelderblom, H.
Gronchi, A.
European Org Res
Treatment Canc Soft Tissue Bone Sa

June 2020

Background The optimal treatment for advanced leiomyosarcoma is still debated. Given histotype-speci...

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour : a multicentre, single-arm, phase 2 trial

J. Martin-Broto
S. Stacchiotti
A. Lopez-Pousa
A. Redondo
D. Bernabeu
E. de Alava
P.G. Casali
A. Italiano
A. Gutierrez
D.S. Moura
M. Pe&#241
J. Diaz-Martin
M. Biscuola
M. Taron
P. Collini
D. Ranchere-Vince
X. Garcia del Muro
G. Grignani
S. Dumont
J. Martinez-Trufero
E. Palmerini
N. Hindi
A. Sebio
J. Dopazo
A.P. Dei Tos
A. Lecesne
J. Blay
J. Cruz

January 2019

Background: A solitary fibrous tumour is a rare soft-tissue tumour with three clinicopathological va...

Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience

Nicholas DeVito (813887)
Evita Henderson (813888)
Gang Han (127634)
Damon Reed (387107)
Marilyn M. Bui (387110)
Robert Lavey (813889)
Lary Robinson (813890)
Jonathan S. Zager (712780)
Ricardo J. Gonzalez (813891)
Vernon K. Sondak (116306)
G. Douglas Letson (813892)
Anthony Conley (813893)

October 2015

<div><p>Solitary fibrous tumor (SFT) is a mesenchymal neoplasm of fibrous origin. The 2013 WHO class...

A comprehensive review on solitary fibrous tumor: New insights for new horizons

Martín-Broto, Javier
Mondaza-Hernández, José L.
Moura, David S.
Hindi, Nadia

May 2022

[Simple Summary] Solitary fibrous tumor (SFT) is a malignant condition that exhibits different clini...

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

D'Ambrosio, Lorenzo
Touati, Nathan
Blay, Jean-Yves
Grignani, Giovanni
Flippot, Ronan
Czarnecka, Anna M
Piperno-Neumann, Sophie
Martin-Broto, Javier
Sanfilippo, Roberta
Katz, Daniela
Duffaud, Florence
Vincenzi, Bruno
Stark, Daniel P
Mazzeo, Filomena
Tuchscherer, Armin
Chevreau, Christine
Sherriff, Jenny
Estival, Anna
Litière, Saskia
Sents, Ward
Ray-Coquard, Isabelle
Tolomeo, Francesco
Le Cesne, Axel
Rutkowski, Piotr
Stacchiotti, Silvia
Kasper, Bernd
Gelderblom, Hans
Gronchi, Alessandro
European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

January 2020

BACKGROUND: The optimal treatment for advanced leiomyosarcoma is still debated. Given histotype-spec...

Locally advanced malignant solitary fibrous tumour successfully treated with conversion chemotherapy, operation and postoperative radiotherapy: a case report

Zhi-Ke Li
Jie Liu
Chen Chen
Ke-Yi Yang
Yao-Tiao Deng
Yu Jiang

March 2021

Preoperative diagnosis of solitary fibrous tumour (SFT) may not provide a complete tumour picture an...

A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons

Javier Martin-Broto
Jose L. Mondaza-Hernandez
David S. Moura
Nadia Hindi

June 2021

Solitary fibrous tumor (SFT) is a rare mesenchymal, ubiquitous tumor, with an incidence of 1 new cas...

SOLITARY FIBROUS TUMOR OF THE PLEURA: OUR EXPERIENCE.

July 2015

none8Abstract n. 346 dell'Abstract book, disponibile anche online (http://content.karger.com/Produkt...

A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons.

Martin-Broto, Javier
Mondaza-Hernandez, Jose L
Moura, David S
Hindi, Nadia

June 2021

Solitary fibrous tumor (SFT) is a rare mesenchymal, ubiquitous tumor, with an incidence of 1 new cas...

A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group. Ann Oncol 6:77–79

M. Di Bartolomeo
E. Bajetta
A. M. Bochicchio
C. Carnaghi
L. Somma
V. Mazzaferro
M. Visini
V. Gebbia
S. Tumolo
P. Ballatore

January 1995

Background: Previous experiences in the treatment of neuro-endocrine tumours have demonstrated some ...

Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour

February 2018

none22noBackground Preclinical models that mimic pathological and molecular features of solitary fib...

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience.

Levard, Alice
Derbel, Olfa
Méeus, Pierre
Ranchère, Dominique
Ray-Coquard, Isabelle
Blay, Jean-Yves
Cassier, Philippe

January 2013

International audienceBACKGROUND: Solitary Fibrous Tumor is a rare type of soft tissue tumor of inte...

Dacarbazine in solitary fibrous tumor : a case series analysis and preclinical evidence vis-à-vis temozolomide and antiangiogenics

S. Stacchiotti
M. Tortoreto
F. Bozzi
E. Tamborini
C. Morosi
A. Messina
M. Libertini
E. Palassini
D. Cominetti
T. Negri
A. Gronchi
S. Pilotti
N. Zaffaroni
P.G. Casali

January 2013

Purpose: To explore the value of triazines in solitary fibrous tumor (SFT). Experimental Design: We ...

Multi-institutional European single-arm phase II trial of pazopanib in advanced malignant/dedifferentiated solitary fibrous tumors (SFT): A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) sarcoma groups study.

June 2017

none19openJavier Martin Broto; Silvia Stacchiotti; Antonio Lopez-Pousa; Andres Redondo; Daniel Berna...

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

Martin-Broto, Javier
Stacchiotti, Silvia
Lopez-Pousa, Antonio
Redondo, Andres
Bernabeu, Daniel
de Alava, Enrique
Casali, Paolo G
Italiano, Antoine
Gutierrez, Antonio
Moura, David S
Peña-Chilet, Maria
Diaz-Martin, Juan
Biscuola, Michele
Taron, Miguel
Collini, Paola
Ranchere-Vince, Dominique
Garcia del Muro, Xavier
Grignani, Giovanni
Dumont, Sarah
Martinez-Trufero, Javier
Palmerini, Emanuela
Hindi, Nadia
Sebio, Ana
Dopazo, Joaquin
Dei Tos, Angelo Paolo
LeCesne, Axel
Blay, Jean-Yves
Cruz, Josefina

January 2019

Background: A solitary fibrous tumour is a rare soft-tissue tumour with three clinicopathological va...

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: a propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

D'Ambrosio, L.
Touati, N.
Blay, J.Y.
Grignani, G.
Flippot, R.
Czarnecka, A.M.
Piperno-Neumann, S.
Martin-Broto, J.
Sanfilippo, R.
Katz, D.
Duffaud, F.
Vincenzi, B.
Stark, D.P.
Mazzeo, F.
Tuchscherer, A.
Chevreau, C.
Sherriff, J.
Estival, A.
Litiere, S.
Sents, W.
Ray-Coquard, I.
Tolomeo, F.
Cesne, A. le
Rutkowski, P.
Stacchiotti, S.
Kasper, B.
Gelderblom, H.
Gronchi, A.
European Org Res
Treatment Canc Soft Tissue Bone Sa

June 2020

Background The optimal treatment for advanced leiomyosarcoma is still debated. Given histotype-speci...

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour : a multicentre, single-arm, phase 2 trial

J. Martin-Broto
S. Stacchiotti
A. Lopez-Pousa
A. Redondo
D. Bernabeu
E. de Alava
P.G. Casali
A. Italiano
A. Gutierrez
D.S. Moura
M. Pe&#241
J. Diaz-Martin
M. Biscuola
M. Taron
P. Collini
D. Ranchere-Vince
X. Garcia del Muro
G. Grignani
S. Dumont
J. Martinez-Trufero
E. Palmerini
N. Hindi
A. Sebio
J. Dopazo
A.P. Dei Tos
A. Lecesne
J. Blay
J. Cruz

January 2019

Background: A solitary fibrous tumour is a rare soft-tissue tumour with three clinicopathological va...

Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience

Nicholas DeVito (813887)
Evita Henderson (813888)
Gang Han (127634)
Damon Reed (387107)
Marilyn M. Bui (387110)
Robert Lavey (813889)
Lary Robinson (813890)
Jonathan S. Zager (712780)
Ricardo J. Gonzalez (813891)
Vernon K. Sondak (116306)
G. Douglas Letson (813892)
Anthony Conley (813893)

October 2015

<div><p>Solitary fibrous tumor (SFT) is a mesenchymal neoplasm of fibrous origin. The 2013 WHO class...

A comprehensive review on solitary fibrous tumor: New insights for new horizons

Martín-Broto, Javier
Mondaza-Hernández, José L.
Moura, David S.
Hindi, Nadia

May 2022

[Simple Summary] Solitary fibrous tumor (SFT) is a malignant condition that exhibits different clini...

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

D'Ambrosio, Lorenzo
Touati, Nathan
Blay, Jean-Yves
Grignani, Giovanni
Flippot, Ronan
Czarnecka, Anna M
Piperno-Neumann, Sophie
Martin-Broto, Javier
Sanfilippo, Roberta
Katz, Daniela
Duffaud, Florence
Vincenzi, Bruno
Stark, Daniel P
Mazzeo, Filomena
Tuchscherer, Armin
Chevreau, Christine
Sherriff, Jenny
Estival, Anna
Litière, Saskia
Sents, Ward
Ray-Coquard, Isabelle
Tolomeo, Francesco
Le Cesne, Axel
Rutkowski, Piotr
Stacchiotti, Silvia
Kasper, Bernd
Gelderblom, Hans
Gronchi, Alessandro
European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

January 2020

BACKGROUND: The optimal treatment for advanced leiomyosarcoma is still debated. Given histotype-spec...

Locally advanced malignant solitary fibrous tumour successfully treated with conversion chemotherapy, operation and postoperative radiotherapy: a case report

Zhi-Ke Li
Jie Liu
Chen Chen
Ke-Yi Yang
Yao-Tiao Deng
Yu Jiang

March 2021

Preoperative diagnosis of solitary fibrous tumour (SFT) may not provide a complete tumour picture an...

A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons

Javier Martin-Broto
Jose L. Mondaza-Hernandez
David S. Moura
Nadia Hindi

June 2021

Solitary fibrous tumor (SFT) is a rare mesenchymal, ubiquitous tumor, with an incidence of 1 new cas...

SOLITARY FIBROUS TUMOR OF THE PLEURA: OUR EXPERIENCE.

July 2015

none8Abstract n. 346 dell'Abstract book, disponibile anche online (http://content.karger.com/Produkt...

A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons.

Martin-Broto, Javier
Mondaza-Hernandez, Jose L
Moura, David S
Hindi, Nadia

June 2021

Solitary fibrous tumor (SFT) is a rare mesenchymal, ubiquitous tumor, with an incidence of 1 new cas...

A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group. Ann Oncol 6:77–79

M. Di Bartolomeo
E. Bajetta
A. M. Bochicchio
C. Carnaghi
L. Somma
V. Mazzaferro
M. Visini
V. Gebbia
S. Tumolo
P. Ballatore

January 1995

Background: Previous experiences in the treatment of neuro-endocrine tumours have demonstrated some ...

Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.

Abstract

Extracted data

Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.

Abstract

Extracted data

Related items

Related items